New IMI Funding For EU Research Into ATMPs, Health Outcomes & Drug Info

Projects on T cells and advanced therapy medicinal products for rare diseases, patient reported outcomes in cancer clinical trials, and improvements to patient drug information are among the latest topics to be offered funding under Europe’s Innovative Medicines Initiative.